Ann: ASX Relisting and Market Update, page-7

Key positives for me:
7. Building of chip inventory of 40,370 units (+ additional pending chip orders) for the production of the CONNEQT Pulse;
8. Pre-launch order pipeline for the CONNEQT Pulse of >$USD500,000;
9. Trial production underway for CONNEQT Pulse in anticipation of commercial launch in H12024;
10. A new agreement with SunTech Medical for Oscar 2 ABPM which expands the Company’ssales territories and revenue opportunities for this device;
11. Completion of the Blumio acquisition;
12. Successful clinical validation of the CONNEQT Band technology (as a pre-cursor to regulatory approval being sought - anticipated to be July 2024)

so some time in H12024, there should be Ann that will boost the SP.